Request for Covid-19 Impact Assessment of this Report
The United States Therapeutic Radioisotopes market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Therapeutic Radioisotopes market, reaching US$ million by the year 2028. As for the Europe Therapeutic Radioisotopes landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Therapeutic Radioisotopes players cover Bayer, Novartis, China Isotope & Radiation, and Dongcheng, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Radioisotopes market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Radium-223
Lutetium-177
Iodine-131
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Thyroid
Bone Metastasis
Lymphoma
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Therapeutic Radioisotopes Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Therapeutic Radioisotopes by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Therapeutic Radioisotopes by Country/Region, 2017, 2022 & 2028
2.2 Therapeutic Radioisotopes Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Therapeutic Radioisotopes Sales by Type
2.3.1 Global Therapeutic Radioisotopes Sales Market Share by Type (2017-2022)
2.3.2 Global Therapeutic Radioisotopes Revenue and Market Share by Type (2017-2022)
2.3.3 Global Therapeutic Radioisotopes Sale Price by Type (2017-2022)
2.4 Therapeutic Radioisotopes Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Therapeutic Radioisotopes Sales by Application
2.5.1 Global Therapeutic Radioisotopes Sale Market Share by Application (2017-2022)
2.5.2 Global Therapeutic Radioisotopes Revenue and Market Share by Application (2017-2022)
2.5.3 Global Therapeutic Radioisotopes Sale Price by Application (2017-2022)
3 Global Therapeutic Radioisotopes by Company
3.1 Global Therapeutic Radioisotopes Breakdown Data by Company
3.1.1 Global Therapeutic Radioisotopes Annual Sales by Company (2020-2022)
3.1.2 Global Therapeutic Radioisotopes Sales Market Share by Company (2020-2022)
3.2 Global Therapeutic Radioisotopes Annual Revenue by Company (2020-2022)
3.2.1 Global Therapeutic Radioisotopes Revenue by Company (2020-2022)
3.2.2 Global Therapeutic Radioisotopes Revenue Market Share by Company (2020-2022)
3.3 Global Therapeutic Radioisotopes Sale Price by Company
3.4 Key Manufacturers Therapeutic Radioisotopes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Therapeutic Radioisotopes Product Location Distribution
3.4.2 Players Therapeutic Radioisotopes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Therapeutic Radioisotopes by Geographic Region
4.1 World Historic Therapeutic Radioisotopes Market Size by Geographic Region (2017-2022)
4.1.1 Global Therapeutic Radioisotopes Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Therapeutic Radioisotopes Annual Revenue by Geographic Region
4.2 World Historic Therapeutic Radioisotopes Market Size by Country/Region (2017-2022)
4.2.1 Global Therapeutic Radioisotopes Annual Sales by Country/Region (2017-2022)
4.2.2 Global Therapeutic Radioisotopes Annual Revenue by Country/Region
4.3 Americas Therapeutic Radioisotopes Sales Growth
4.4 APAC Therapeutic Radioisotopes Sales Growth
4.5 Europe Therapeutic Radioisotopes Sales Growth
4.6 Middle East & Africa Therapeutic Radioisotopes Sales Growth
5 Americas
5.1 Americas Therapeutic Radioisotopes Sales by Country
5.1.1 Americas Therapeutic Radioisotopes Sales by Country (2017-2022)
5.1.2 Americas Therapeutic Radioisotopes Revenue by Country (2017-2022)
5.2 Americas Therapeutic Radioisotopes Sales by Type
5.3 Americas Therapeutic Radioisotopes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Therapeutic Radioisotopes Sales by Region
6.1.1 APAC Therapeutic Radioisotopes Sales by Region (2017-2022)
6.1.2 APAC Therapeutic Radioisotopes Revenue by Region (2017-2022)
6.2 APAC Therapeutic Radioisotopes Sales by Type
6.3 APAC Therapeutic Radioisotopes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Therapeutic Radioisotopes by Country
7.1.1 Europe Therapeutic Radioisotopes Sales by Country (2017-2022)
7.1.2 Europe Therapeutic Radioisotopes Revenue by Country (2017-2022)
7.2 Europe Therapeutic Radioisotopes Sales by Type
7.3 Europe Therapeutic Radioisotopes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Therapeutic Radioisotopes by Country
8.1.1 Middle East & Africa Therapeutic Radioisotopes Sales by Country (2017-2022)
8.1.2 Middle East & Africa Therapeutic Radioisotopes Revenue by Country (2017-2022)
8.2 Middle East & Africa Therapeutic Radioisotopes Sales by Type
8.3 Middle East & Africa Therapeutic Radioisotopes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Therapeutic Radioisotopes
10.3 Manufacturing Process Analysis of Therapeutic Radioisotopes
10.4 Industry Chain Structure of Therapeutic Radioisotopes
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Therapeutic Radioisotopes Distributors
11.3 Therapeutic Radioisotopes Customer
12 World Forecast Review for Therapeutic Radioisotopes by Geographic Region
12.1 Global Therapeutic Radioisotopes Market Size Forecast by Region
12.1.1 Global Therapeutic Radioisotopes Forecast by Region (2023-2028)
12.1.2 Global Therapeutic Radioisotopes Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Therapeutic Radioisotopes Forecast by Type
12.7 Global Therapeutic Radioisotopes Forecast by Application
13 Key Players Analysis
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Therapeutic Radioisotopes Product Offered
13.1.3 Bayer Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Novartis
13.2.1 Novartis Company Information
13.2.2 Novartis Therapeutic Radioisotopes Product Offered
13.2.3 Novartis Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis Main Business Overview
13.2.5 Novartis Latest Developments
13.3 China Isotope & Radiation
13.3.1 China Isotope & Radiation Company Information
13.3.2 China Isotope & Radiation Therapeutic Radioisotopes Product Offered
13.3.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 China Isotope & Radiation Main Business Overview
13.3.5 China Isotope & Radiation Latest Developments
13.4 Dongcheng
13.4.1 Dongcheng Company Information
13.4.2 Dongcheng Therapeutic Radioisotopes Product Offered
13.4.3 Dongcheng Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Dongcheng Main Business Overview
13.4.5 Dongcheng Latest Developments
13.5 Q BioMed
13.5.1 Q BioMed Company Information
13.5.2 Q BioMed Therapeutic Radioisotopes Product Offered
13.5.3 Q BioMed Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Q BioMed Main Business Overview
13.5.5 Q BioMed Latest Developments
13.6 Curium Pharmaceuticals
13.6.1 Curium Pharmaceuticals Company Information
13.6.2 Curium Pharmaceuticals Therapeutic Radioisotopes Product Offered
13.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Curium Pharmaceuticals Main Business Overview
13.6.5 Curium Pharmaceuticals Latest Developments
13.7 Jubilant DraxImage
13.7.1 Jubilant DraxImage Company Information
13.7.2 Jubilant DraxImage Therapeutic Radioisotopes Product Offered
13.7.3 Jubilant DraxImage Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Jubilant DraxImage Main Business Overview
13.7.5 Jubilant DraxImage Latest Developments
13.8 Lantheus
13.8.1 Lantheus Company Information
13.8.2 Lantheus Therapeutic Radioisotopes Product Offered
13.8.3 Lantheus Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Lantheus Main Business Overview
13.8.5 Lantheus Latest Developments
13.9 Spectrum Pharmaceuticals
13.9.1 Spectrum Pharmaceuticals Company Information
13.9.2 Spectrum Pharmaceuticals Therapeutic Radioisotopes Product Offered
13.9.3 Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Spectrum Pharmaceuticals Main Business Overview
13.9.5 Spectrum Pharmaceuticals Latest Developments
13.10 Progenics Pharmaceuticals
13.10.1 Progenics Pharmaceuticals Company Information
13.10.2 Progenics Pharmaceuticals Therapeutic Radioisotopes Product Offered
13.10.3 Progenics Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Progenics Pharmaceuticals Main Business Overview
13.10.5 Progenics Pharmaceuticals Latest Developments
13.11 International Isotopes
13.11.1 International Isotopes Company Information
13.11.2 International Isotopes Therapeutic Radioisotopes Product Offered
13.11.3 International Isotopes Therapeutic Radioisotopes Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 International Isotopes Main Business Overview
13.11.5 International Isotopes Latest Developments
14 Research Findings and Conclusion
Table 1. Therapeutic Radioisotopes Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Therapeutic Radioisotopes Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Radium-223
Table 4. Major Players of Lutetium-177
Table 5. Major Players of Iodine-131
Table 6. Major Players of Other
Table 7. Global Therapeutic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 8. Global Therapeutic Radioisotopes Sales Market Share by Type (2017-2022)
Table 9. Global Therapeutic Radioisotopes Revenue by Type (2017-2022) & ($ million)
Table 10. Global Therapeutic Radioisotopes Revenue Market Share by Type (2017-2022)
Table 11. Global Therapeutic Radioisotopes Sale Price by Type (2017-2022) & (USD/Unit)
Table 12. Global Therapeutic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 13. Global Therapeutic Radioisotopes Sales Market Share by Application (2017-2022)
Table 14. Global Therapeutic Radioisotopes Revenue by Application (2017-2022)
Table 15. Global Therapeutic Radioisotopes Revenue Market Share by Application (2017-2022)
Table 16. Global Therapeutic Radioisotopes Sale Price by Application (2017-2022) & (USD/Unit)
Table 17. Global Therapeutic Radioisotopes Sales by Company (2020-2022) & (K Units)
Table 18. Global Therapeutic Radioisotopes Sales Market Share by Company (2020-2022)
Table 19. Global Therapeutic Radioisotopes Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Therapeutic Radioisotopes Revenue Market Share by Company (2020-2022)
Table 21. Global Therapeutic Radioisotopes Sale Price by Company (2020-2022) & (USD/Unit)
Table 22. Key Manufacturers Therapeutic Radioisotopes Producing Area Distribution and Sales Area
Table 23. Players Therapeutic Radioisotopes Products Offered
Table 24. Therapeutic Radioisotopes Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Therapeutic Radioisotopes Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Therapeutic Radioisotopes Sales Market Share Geographic Region (2017-2022)
Table 29. Global Therapeutic Radioisotopes Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Therapeutic Radioisotopes Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Therapeutic Radioisotopes Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Therapeutic Radioisotopes Sales Market Share by Country/Region (2017-2022)
Table 33. Global Therapeutic Radioisotopes Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Therapeutic Radioisotopes Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Therapeutic Radioisotopes Sales by Country (2017-2022) & (K Units)
Table 36. Americas Therapeutic Radioisotopes Sales Market Share by Country (2017-2022)
Table 37. Americas Therapeutic Radioisotopes Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Therapeutic Radioisotopes Revenue Market Share by Country (2017-2022)
Table 39. Americas Therapeutic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 40. Americas Therapeutic Radioisotopes Sales Market Share by Type (2017-2022)
Table 41. Americas Therapeutic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 42. Americas Therapeutic Radioisotopes Sales Market Share by Application (2017-2022)
Table 43. APAC Therapeutic Radioisotopes Sales by Region (2017-2022) & (K Units)
Table 44. APAC Therapeutic Radioisotopes Sales Market Share by Region (2017-2022)
Table 45. APAC Therapeutic Radioisotopes Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Therapeutic Radioisotopes Revenue Market Share by Region (2017-2022)
Table 47. APAC Therapeutic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 48. APAC Therapeutic Radioisotopes Sales Market Share by Type (2017-2022)
Table 49. APAC Therapeutic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 50. APAC Therapeutic Radioisotopes Sales Market Share by Application (2017-2022)
Table 51. Europe Therapeutic Radioisotopes Sales by Country (2017-2022) & (K Units)
Table 52. Europe Therapeutic Radioisotopes Sales Market Share by Country (2017-2022)
Table 53. Europe Therapeutic Radioisotopes Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Therapeutic Radioisotopes Revenue Market Share by Country (2017-2022)
Table 55. Europe Therapeutic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 56. Europe Therapeutic Radioisotopes Sales Market Share by Type (2017-2022)
Table 57. Europe Therapeutic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 58. Europe Therapeutic Radioisotopes Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Therapeutic Radioisotopes Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Therapeutic Radioisotopes Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Therapeutic Radioisotopes Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Therapeutic Radioisotopes Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Therapeutic Radioisotopes Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Therapeutic Radioisotopes Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Therapeutic Radioisotopes Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Therapeutic Radioisotopes Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Therapeutic Radioisotopes
Table 68. Key Market Challenges & Risks of Therapeutic Radioisotopes
Table 69. Key Industry Trends of Therapeutic Radioisotopes
Table 70. Therapeutic Radioisotopes Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Therapeutic Radioisotopes Distributors List
Table 73. Therapeutic Radioisotopes Customer List
Table 74. Global Therapeutic Radioisotopes Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Therapeutic Radioisotopes Sales Market Forecast by Region
Table 76. Global Therapeutic Radioisotopes Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Therapeutic Radioisotopes Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Therapeutic Radioisotopes Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Therapeutic Radioisotopes Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Therapeutic Radioisotopes Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Therapeutic Radioisotopes Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Therapeutic Radioisotopes Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Therapeutic Radioisotopes Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Therapeutic Radioisotopes Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Therapeutic Radioisotopes Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Therapeutic Radioisotopes Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Therapeutic Radioisotopes Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Therapeutic Radioisotopes Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Therapeutic Radioisotopes Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Therapeutic Radioisotopes Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Therapeutic Radioisotopes Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Therapeutic Radioisotopes Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Therapeutic Radioisotopes Revenue Market Share Forecast by Application (2023-2028)
Table 94. Bayer Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 95. Bayer Therapeutic Radioisotopes Product Offered
Table 96. Bayer Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 97. Bayer Main Business
Table 98. Bayer Latest Developments
Table 99. Novartis Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 100. Novartis Therapeutic Radioisotopes Product Offered
Table 101. Novartis Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 102. Novartis Main Business
Table 103. Novartis Latest Developments
Table 104. China Isotope & Radiation Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 105. China Isotope & Radiation Therapeutic Radioisotopes Product Offered
Table 106. China Isotope & Radiation Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 107. China Isotope & Radiation Main Business
Table 108. China Isotope & Radiation Latest Developments
Table 109. Dongcheng Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 110. Dongcheng Therapeutic Radioisotopes Product Offered
Table 111. Dongcheng Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 112. Dongcheng Main Business
Table 113. Dongcheng Latest Developments
Table 114. Q BioMed Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 115. Q BioMed Therapeutic Radioisotopes Product Offered
Table 116. Q BioMed Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 117. Q BioMed Main Business
Table 118. Q BioMed Latest Developments
Table 119. Curium Pharmaceuticals Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 120. Curium Pharmaceuticals Therapeutic Radioisotopes Product Offered
Table 121. Curium Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 122. Curium Pharmaceuticals Main Business
Table 123. Curium Pharmaceuticals Latest Developments
Table 124. Jubilant DraxImage Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 125. Jubilant DraxImage Therapeutic Radioisotopes Product Offered
Table 126. Jubilant DraxImage Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 127. Jubilant DraxImage Main Business
Table 128. Jubilant DraxImage Latest Developments
Table 129. Lantheus Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 130. Lantheus Therapeutic Radioisotopes Product Offered
Table 131. Lantheus Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 132. Lantheus Main Business
Table 133. Lantheus Latest Developments
Table 134. Spectrum Pharmaceuticals Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 135. Spectrum Pharmaceuticals Therapeutic Radioisotopes Product Offered
Table 136. Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 137. Spectrum Pharmaceuticals Main Business
Table 138. Spectrum Pharmaceuticals Latest Developments
Table 139. Progenics Pharmaceuticals Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 140. Progenics Pharmaceuticals Therapeutic Radioisotopes Product Offered
Table 141. Progenics Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 142. Progenics Pharmaceuticals Main Business
Table 143. Progenics Pharmaceuticals Latest Developments
Table 144. International Isotopes Basic Information, Therapeutic Radioisotopes Manufacturing Base, Sales Area and Its Competitors
Table 145. International Isotopes Therapeutic Radioisotopes Product Offered
Table 146. International Isotopes Therapeutic Radioisotopes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 147. International Isotopes Main Business
Table 148. International Isotopes Latest Developments
List of Figures
Figure 1. Picture of Therapeutic Radioisotopes
Figure 2. Therapeutic Radioisotopes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Therapeutic Radioisotopes Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Therapeutic Radioisotopes Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Therapeutic Radioisotopes Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Radium-223
Figure 10. Product Picture of Lutetium-177
Figure 11. Product Picture of Iodine-131
Figure 12. Product Picture of Other
Figure 13. Global Therapeutic Radioisotopes Sales Market Share by Type in 2021
Figure 14. Global Therapeutic Radioisotopes Revenue Market Share by Type (2017-2022)
Figure 15. Therapeutic Radioisotopes Consumed in Thyroid
Figure 16. Global Therapeutic Radioisotopes Market: Thyroid (2017-2022) & (K Units)
Figure 17. Therapeutic Radioisotopes Consumed in Bone Metastasis
Figure 18. Global Therapeutic Radioisotopes Market: Bone Metastasis (2017-2022) & (K Units)
Figure 19. Therapeutic Radioisotopes Consumed in Lymphoma
Figure 20. Global Therapeutic Radioisotopes Market: Lymphoma (2017-2022) & (K Units)
Figure 21. Therapeutic Radioisotopes Consumed in Other
Figure 22. Global Therapeutic Radioisotopes Market: Other (2017-2022) & (K Units)
Figure 23. Global Therapeutic Radioisotopes Sales Market Share by Application (2017-2022)
Figure 24. Global Therapeutic Radioisotopes Revenue Market Share by Application in 2021
Figure 25. Therapeutic Radioisotopes Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Therapeutic Radioisotopes Revenue Market Share by Company in 2021
Figure 27. Global Therapeutic Radioisotopes Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Therapeutic Radioisotopes Revenue Market Share by Geographic Region in 2021
Figure 29. Global Therapeutic Radioisotopes Sales Market Share by Region (2017-2022)
Figure 30. Global Therapeutic Radioisotopes Revenue Market Share by Country/Region in 2021
Figure 31. Americas Therapeutic Radioisotopes Sales 2017-2022 (K Units)
Figure 32. Americas Therapeutic Radioisotopes Revenue 2017-2022 ($ Millions)
Figure 33. APAC Therapeutic Radioisotopes Sales 2017-2022 (K Units)
Figure 34. APAC Therapeutic Radioisotopes Revenue 2017-2022 ($ Millions)
Figure 35. Europe Therapeutic Radioisotopes Sales 2017-2022 (K Units)
Figure 36. Europe Therapeutic Radioisotopes Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Therapeutic Radioisotopes Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Therapeutic Radioisotopes Revenue 2017-2022 ($ Millions)
Figure 39. Americas Therapeutic Radioisotopes Sales Market Share by Country in 2021
Figure 40. Americas Therapeutic Radioisotopes Revenue Market Share by Country in 2021
Figure 41. United States Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Therapeutic Radioisotopes Sales Market Share by Region in 2021
Figure 46. APAC Therapeutic Radioisotopes Revenue Market Share by Regions in 2021
Figure 47. China Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Therapeutic Radioisotopes Sales Market Share by Country in 2021
Figure 54. Europe Therapeutic Radioisotopes Revenue Market Share by Country in 2021
Figure 55. Germany Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Therapeutic Radioisotopes Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Therapeutic Radioisotopes Revenue Market Share by Country in 2021
Figure 62. Egypt Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Therapeutic Radioisotopes Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Therapeutic Radioisotopes in 2021
Figure 68. Manufacturing Process Analysis of Therapeutic Radioisotopes
Figure 69. Industry Chain Structure of Therapeutic Radioisotopes
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...